Showing results (21-30 of 187) with videos related to
Sort By:
Pageof 19
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
Interleukin 6 inhibition - RA and beyondRobert S Woodrick, Eric M RudermanPostgraduate Medicine|December 8, 2004
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destructionSakeba N Issa, Eric M RudermanBulletin of the NYU Hospital for Joint Diseases|December 25, 2012
IL-6 inhibition for the treatment of rheumatoid arthritis and other conditionsRobert S Woodrick, Eric M RudermanArthritis Research & Therapy|April 19, 2005
The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritisEric M Ruderman, Richard M PopeJournal of the American Academy of Dermatology|February 21, 2006
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approachKenneth B Gordon, Eric M RudermanNature Clinical Practice. Rheumatology|November 30, 2006
Drug Insight: abatacept for the treatment of rheumatoid arthritisEric M Ruderman, Richard M PopeNature Reviews. Rheumatology|October 13, 2011
Safety of biologic therapy in rheumatoid arthritisRobert S Woodrick, Eric M RudermanRheumatic Diseases Clinics of North America|October 18, 2015
Natural History, Prognosis, and Socioeconomic Aspects of Psoriatic ArthritisPhilip S Helliwell, Eric M RudermanFrontiers in Immunology|August 22, 2024
Traversing the bench to bedside journey for iNKT cell therapiesJulie O'Neal, Melissa Mavers, Reyka G Jayasinghe, et al.Journal of Pediatric Hematology/Oncology|December 27, 2019
Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18 y) With Early Relapse Hodgkin LymphomaKaren S Fernández, Melissa Mavers, Lianna J Marks, et al.Pageof 19